Articles: PDF OnlyClub Drugs, Part I: MDMATeter, Christian J. PharmD, BCPP Author Information Post-Doctoral Fellow (NIDA), College of Pharmacy & Substance Abuse Research Center, University of Michigan The author has disclosed that he has no significant relationships with or financial interests in any commercial organizations pertaining to this educational activity. This article is adapted from Teter CJ and Guthrie SK, A comprehensive review of MDMA and GHB: Two common club drugs. Pharmacotherapy 2001;21:1486–1513. Reprinted with permission. International Drug Therapy Newsletter: July 2003 - Volume 38 - Issue 7 - p 49-56 Buy Abstract Learning Objectives: After reading this article, the practitioner should be able to: Discuss the socially designated class of drugs known as “club drugs” and the public health concern about them. Describe the pharmacokinetic parameters of methylenedioxymethamphetamine (MDMA). Discuss both the animal and human evidence of serotonergic neurotoxicity associated with MDMA use. Recognize the signs and symptoms of acute adverse reactions associated with MDMA ingestion and explain possible treatment options for an acute adverse reaction secondary to MDMA ingestion. © 2003 Lippincott Williams & Wilkins, Inc.